John Mao Selected Research

GST-HG131

1/2022

Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Mao Research Topics

Disease

3	Neoplasms (Cancer) 07/2002 - 01/2002
2	Dizziness (Lightheadedness) 01/2022 - 09/2012
2	Nausea 01/2022 - 01/2002
2	Diarrhea 11/2006 - 01/2002
1	Infections 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Fatigue 09/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2012
1	Chronic Hepatitis C 11/2006
1	Bacteremia 01/2002
1	Hyperbilirubinemia 01/2002
1	Thrombocytopenia (Thrombopenia) 01/2002
1	Vomiting 01/2002
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2002
1	Anemia 01/2002
1	Melanoma (Melanoma, Malignant) 01/2002
1	Hypophosphatemia 01/2002

Drug/Important Bio-Agent (IBA)

2	VNP 20009 (VNP20009)IBA 07/2002 - 01/2002
1	GST-HG131IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	SuspensionsIBA 01/2020
1	AndrogensIBA 01/2020
1	Mesylates (Mesylate)IBA 01/2020
1	Leuprolide (Lupron)FDA LinkGeneric 01/2020
1	CK-2017357IBA 09/2012
1	TroponinIBA 09/2012
1	2'-C-methylcytidineIBA 11/2006
1	EnzymesIBA 07/2002
1	Fluorouracil (Carac)FDA LinkGeneric 07/2002
1	ProdrugsIBA 07/2002
1	Cytosine DeaminaseIBA 07/2002
1	Antineoplastic Agents (Antineoplastics)IBA 07/2002
1	laromustine (VNP40101M)IBA 01/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2002
1	Alkaline PhosphataseIBA 01/2002
1	Alkylating AgentsIBA 01/2002
1	hydrazine (hydrazine dihydrochloride)IBA 01/2002

Therapy/Procedure

2	Intravenous Administration 07/2002 - 01/2002
1	Injections 01/2020
1	Subcutaneous Injections 01/2020
1	Therapeutics 01/2020
1	Intravenous Infusions 01/2002